MTOR and acute myeloid leukemia: Considering the poor clinical efficacy of a single treatment with mTOR inhibitors [58, 59], we then investigated whether 8GL could potentiate the anticancer efficacy of everolimus via the co-inhibition of the mTOR pathway in AML.